A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302
NCT02468570
·
clinicaltrials.gov ↗
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Phenylketonuria
Interventions
OTHER:
Administration of CANTAB and Subject Global Assessment
Sponsor
BioMarin Pharmaceutical